Malcolm Bull
Head of Australian Operations and Investor Relations
Replay available
Clinuvel Pharmaceuticals Limited (CUV) Q4 2026 Earnings Call
Clinuvel Pharmaceuticals Limited (ASX: CUV) Q4 2026 earnings conference call, held 2026-08-27. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Peter Vaughan
Chief Financial Officer
Emily Rottenberger
Director of Global Clinical Affairs
Philippe Walden
Managing Director
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Clinuvel Pharmaceuticals Limited.
Replay transcript excerpt
WEBVTT 00:00:01.330 -- 00:00:05.111 Hello everyone, thank you for joining CleanWevel's investor webinar today. 00:00:05.111 -- 00:00:07.572 I'm Stella of Monsoon Communications. 00:00:07.572 -- 00:00:11.553 In today's webinar, CleanWevel will share their results and operational highlights for 00:00:11.553 -- 00:00:15.394 the financial year ended on the 30th June 2026. 00:00:15.394 -- 00:00:20.395 I will now hand over to Malcolm Bull, Head of Australian Operations and Investor Relations 00:00:20.395 -- 00:00:22.915 to conduct the proceedings. 00:00:22.970 -- 00:00:28.134 Thank you Stella and thank you to Monsoon for hosting yet another Cliniovel 00:00:28.134 -- 00:00:31.737 results webinar. Welcome everybody on the line. 00:00:31.737 -- 00:00:36.521 There should be 130 of you very attentive to the news that we're going to provide to 00:00:36.521 -- 00:00:41.646 you. I have CFO Peter Vaughan on the line 00:00:41.646 -- 00:00:46.850 as well as our Director of Global Clinical Affairs Emily Rottenberger on the line 00:00:46.850 -- 00:00:51.997 and Managing Director Philippe Walden. Welcome executives. 00:00:51.997 -- 00:00:52.637 Thank you. 00:00:52.637 -- 00:00:54.918 Hello. Good morning. 00:00:54.918 -- 00:01:00.339 Good. The agenda today is to discuss our results for the financial 00:01:00.339 -- 00:01:03.680 year ending 30 June 2026. 00:01:03.680 -- 00:01:09.142 And we're going to have Philippe and Peter and Emily involved in various aspects of 00:01:09.142 -- 00:01:12.302 the performance and operations of the business. 00:01:12.302 -- 00:01:17.244 We also announced some other news today, the consideration of listing all of our ordinary 00:01:17.244 -- 00:01:22.697 shares on the NASDAQ. and delisting from the ASX and we'll certainly get Philippe 00:01:22.697 -- 00:01:...